Literature DB >> 25769542

Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates.

Judith M Boer1, Jasper E Koenders2, Bronno van der Holt3, Carla Exalto2, Mathijs A Sanders2, Jan J Cornelissen2, Peter J M Valk2, Monique L den Boer4, Anita W Rijneveld5.   

Abstract

Entities:  

Keywords:  B-cell precursor acute lymphoblastic leukemia; BCR-ABL-like acute lymphoblastic leukemia; expression profiling; outcome

Mesh：

Substances：

Year:  2015        PMID： 25769542      PMCID： PMC4486237          DOI： 10.3324/haematol.2014.117424

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.

Authors:  J M de Bont; B van der Holt; A W Dekker; A van der Does-van den Berg; P Sonneveld; R Pieters
Journal:  Leukemia       Date:  2004-12       Impact factor: 11.528

2.  IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

Authors:  R P Kuiper; E Waanders; V H J van der Velden; S V van Reijmersdal; R Venkatachalam; B Scheijen; E Sonneveld; J J M van Dongen; A J P Veerman; F N van Leeuwen; A Geurts van Kessel; P M Hoogerbrugge
Journal:  Leukemia       Date:  2010-05-06       Impact factor: 11.528

3.  Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.

Authors:  A W Rijneveld; B van der Holt; S M G J Daenen; B J Biemond; O de Weerdt; P Muus; J Maertens; V Mattijssen; H Demuynck; M C J C Legdeur; P W Wijermans; S Wittebol; F M Spoelstra; A W Dekker; G J Ossenkoppele; R Willemze; J J Cornelissen
Journal:  Leukemia       Date:  2011-06-07       Impact factor: 11.528

4.  IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

Authors:  Giovanni Martinelli; Ilaria Iacobucci; Clelia Tiziana Storlazzi; Marco Vignetti; Francesca Paoloni; Daniela Cilloni; Simona Soverini; Antonella Vitale; Sabina Chiaretti; Giuseppe Cimino; Cristina Papayannidis; Stefania Paolini; Loredana Elia; Paola Fazi; Giovanna Meloni; Sergio Amadori; Giuseppe Saglio; Fabrizio Pane; Michele Baccarani; Robin Foà
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

5.  Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.

Authors:  Jan J Cornelissen; Bronno van der Holt; Gregor E G Verhoef; Mars B van't Veer; Marinus H J van Oers; Harry C Schouten; Gert Ossenkoppele; Pieter Sonneveld; Johan Maertens; Marinus van Marwijk Kooy; Martijn R Schaafsma; Pierre W Wijermans; Douwe H Biesma; Shulamit Wittebol; Paul J Voogt; Joke W Baars; Pierre Zachée; Leo F Verdonck; Bob Löwenberg; Adriaan W Dekker
Journal:  Blood       Date:  2008-11-06       Impact factor: 22.113

6.  BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.

Authors:  Charles G Mullighan; Christopher B Miller; Ina Radtke; Letha A Phillips; James Dalton; Jing Ma; Deborah White; Timothy P Hughes; Michelle M Le Beau; Ching-Hon Pui; Mary V Relling; Sheila A Shurtleff; James R Downing
Journal:  Nature       Date:  2008-04-13       Impact factor: 49.962

7.  A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

Authors:  Monique L Den Boer; Marjon van Slegtenhorst; Renée X De Menezes; Meyling H Cheok; Jessica G C A M Buijs-Gladdines; Susan T C J M Peters; Laura J C M Van Zutven; H Berna Beverloo; Peter J Van der Spek; Gaby Escherich; Martin A Horstmann; Gritta E Janka-Schaub; Willem A Kamps; William E Evans; Rob Pieters
Journal:  Lancet Oncol       Date:  2009-01-08       Impact factor: 41.316

8.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

9.  Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Yongjin Li; Debbie Payne-Turner; Richard C Harvey; Yung-Li Yang; Deqing Pei; Kelly McCastlain; Li Ding; Charles Lu; Guangchun Song; Jing Ma; Jared Becksfort; Michael Rusch; Shann-Ching Chen; John Easton; Jinjun Cheng; Kristy Boggs; Natalia Santiago-Morales; Ilaria Iacobucci; Robert S Fulton; Ji Wen; Marcus Valentine; Cheng Cheng; Steven W Paugh; Meenakshi Devidas; I-Ming Chen; Shalini Reshmi; Amy Smith; Erin Hedlund; Pankaj Gupta; Panduka Nagahawatte; Gang Wu; Xiang Chen; Donald Yergeau; Bhavin Vadodaria; Heather Mulder; Naomi J Winick; Eric C Larsen; William L Carroll; Nyla A Heerema; Andrew J Carroll; Guy Grayson; Sarah K Tasian; Andrew S Moore; Frank Keller; Melissa Frei-Jones; James A Whitlock; Elizabeth A Raetz; Deborah L White; Timothy P Hughes; Jaime M Guidry Auvil; Malcolm A Smith; Guido Marcucci; Clara D Bloomfield; Krzysztof Mrózek; Jessica Kohlschmidt; Wendy Stock; Steven M Kornblau; Marina Konopleva; Elisabeth Paietta; Ching-Hon Pui; Sima Jeha; Mary V Relling; William E Evans; Daniela S Gerhard; Julie M Gastier-Foster; Elaine Mardis; Richard K Wilson; Mignon L Loh; James R Downing; Stephen P Hunger; Cheryl L Willman; Jinghui Zhang; Charles G Mullighan
Journal:  N Engl J Med       Date:  2014-09-11       Impact factor: 91.245

10.  Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

Authors:  Arian van der Veer; Esmé Waanders; Rob Pieters; Marieke E Willemse; Simon V Van Reijmersdal; Lisa J Russell; Christine J Harrison; William E Evans; Vincent H J van der Velden; Peter M Hoogerbrugge; Frank Van Leeuwen; Gabriele Escherich; Martin A Horstmann; Leila Mohammadi Khankahdani; Dimitris Rizopoulos; Hester A De Groot-Kruseman; Edwin Sonneveld; Roland P Kuiper; Monique L Den Boer
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113
View more
  30 in total

1.  Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

Authors:  Shalini C Reshmi; Richard C Harvey; Kathryn G Roberts; Eileen Stonerock; Amy Smith; Heather Jenkins; I-Ming Chen; Marc Valentine; Yu Liu; Yongjin Li; Ying Shao; John Easton; Debbie Payne-Turner; Zhaohui Gu; Thai Hoa Tran; Jonathan V Nguyen; Meenakshi Devidas; Yunfeng Dai; Nyla A Heerema; Andrew J Carroll; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; Anne L Angiolillo; Michael J Burke; Wanda L Salzer; Patrick A Zweidler-McKay; Karen R Rabin; William L Carroll; Jinghui Zhang; Mignon L Loh; Charles G Mullighan; Cheryl L Willman; Julie M Gastier-Foster; Stephen P Hunger
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

Review 2.  Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Authors:  Christopher Wenzinger; Eli Williams; Alejandro A Gru
Journal:  Curr Hematol Malig Rep       Date:  2018-08       Impact factor: 3.952

Review 3.  Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.

Authors:  Ching-Hon Pui; Kathryn G Roberts; Jun J Yang; Charles G Mullighan
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-08

4.  High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Kathryn G Roberts; Zhaohui Gu; Debbie Payne-Turner; Kelly McCastlain; Richard C Harvey; I-Ming Chen; Deqing Pei; Ilaria Iacobucci; Marcus Valentine; Stanley B Pounds; Lei Shi; Yongjin Li; Jinghui Zhang; Cheng Cheng; Alessandro Rambaldi; Manuela Tosi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Peter H Wiernik; Ravi Bhatia; Ibrahim Aldoss; Jessica Kohlschmidt; Krzysztof Mrózek; Guido Marcucci; Clara D Bloomfield; Wendy Stock; Stephen Kornblau; Hagop M Kantarjian; Marina Konopleva; Elisabeth Paietta; Cheryl L Willman; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

Review 5.  Clinical diagnostics and treatment strategies for Philadelphia chromosome-like acute lymphoblastic leukemia.

Authors:  Richard C Harvey; Sarah K Tasian
Journal:  Blood Adv       Date:  2020-01-14

Review 6.  Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.

Authors:  Tobias Herold; Nicola Gökbuget
Journal:  Curr Oncol Rep       Date:  2017-05       Impact factor: 5.075

Review 7.  Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications.

Authors:  Mahsa Mohseni; Hasan Uludag; Joseph M Brandwein
Journal:  Am J Blood Res       Date:  2018-12-10

8.  Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.

Authors:  Sarah K Tasian; David T Teachey; Yong Li; Feng Shen; Richard C Harvey; I-Ming Chen; Theresa Ryan; Tiffaney L Vincent; Cheryl L Willman; Alexander E Perl; Stephen P Hunger; Mignon L Loh; Martin Carroll; Stephan A Grupp
Journal:  Blood       Date:  2016-10-24       Impact factor: 22.113

9.  Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications.

Authors:  Sabina Chiaretti; Monica Messina; Sara Grammatico; Alfonso Piciocchi; Anna L Fedullo; Filomena Di Giacomo; Nadia Peragine; Valentina Gianfelici; Alessia Lauretti; Rohan Bareja; Maria P Martelli; Marco Vignetti; Valerio Apicella; Antonella Vitale; Loretta S Li; Cyril Salek; Olivier Elemento; Giorgio Inghirami; David M Weinstock; Anna Guarini; Robin Foà
Journal:  Br J Haematol       Date:  2018-04-19       Impact factor: 6.998

10.  Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.

Authors:  Tobias Herold; Stephanie Schneider; Klaus H Metzeler; Martin Neumann; Luise Hartmann; Kathryn G Roberts; Nikola P Konstandin; Philipp A Greif; Kathrin Bräundl; Bianka Ksienzyk; Natalia Huk; Irene Schneider; Evelyn Zellmeier; Vindi Jurinovic; Ulrich Mansmann; Wolfgang Hiddemann; Charles G Mullighan; Stefan K Bohlander; Karsten Spiekermann; Dieter Hoelzer; Monika Brüggemann; Claudia D Baldus; Martin Dreyling; Nicola Gökbuget
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.